DOW JONES23,222.09+568.23 2.51%
S&P 5002,720.79+61.38 2.31%
NASDAQ8,036.03+148.77 1.89%

Citigroup Initiates Coverage On Ionis Pharmaceuticals with Buy Rating, Announces $73 Price Target

Citigroup analyst Joel Beatty initiates coverage on Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy rating and a $73 price target.

Benzinga · 03/05/2020 16:44

Citigroup analyst Joel Beatty initiates coverage on Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy rating and a $73 price target.